MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Short-term investments$346,629K Cash and cashequivalents$55,984K Prepaid expenses andother current assets$6,212K Accounts receivable, net$5,000K Property and equipment,gross$462K Total current assets$413,825K Long-term investments$152,874K Other assets andrestricted cash$9,255K Right-of-use operating leaseassets$1,306K Property and equipment,net$185K Less accumulateddepreciation$277K Total assets$577,445K Total liabilities andstockholders' equity$577,445K Total stockholders'equity$546,454K Total liabilities$30,991K Accumulated deficit-$272,297K Additional paid-in capital$818,545K Total currentliabilities$23,855K Deferred revenue$6,068K Long-term operating leaseliabilities$1,068K Accumulated othercomprehensive income$163K Common stock 0.001 parvalue per share...$43K Accrued expenses$15,979K Accounts payable$6,705K Current portion ofdeferred revenue$954K Current portion ofoperating lease...$217K
Balance Sheet
source: myfinsight.com

Dianthus Therapeutics, Inc. DE (DNTH)

Dianthus Therapeutics, Inc. DE (DNTH)